These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 37406771)

  • 1. Longitudinal Associations Between Physical Health Conditions in Childhood and Attention-Deficit/Hyperactivity Disorder Symptoms at Age 17 Years.
    Reed C; Cortese S; Larsson H; Galéra C; Cotton J; Brandt V
    J Am Acad Child Adolesc Psychiatry; 2024 Feb; 63(2):245-254. PubMed ID: 37406771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective associations between ADHD symptoms and physical conditions from early childhood to adolescence: a population-based longitudinal study.
    Galera C; Collet O; Orri M; Navarro M; Castel L; Galesne C; Reed C; Brandt V; Larsson H; Boivin M; Tremblay R; Côté S; Cortese S
    Lancet Child Adolesc Health; 2023 Dec; 7(12):863-874. PubMed ID: 37973252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Attention-Deficit/Hyperactivity Disorder Medications, Externalizing Symptoms, and Suicidality in Children.
    Shoval G; Visoki E; Moore TM; DiDomenico GE; Argabright ST; Huffnagle NJ; Alexander-Bloch AF; Waller R; Keele L; Benton TD; Gur RE; Barzilay R
    JAMA Netw Open; 2021 Jun; 4(6):e2111342. PubMed ID: 34086035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Genetic and Environmental Risks for Attention-Deficit/Hyperactivity Disorder With Hypomanic Symptoms in Youths.
    Hosang GM; Lichtenstein P; Ronald A; Lundström S; Taylor MJ
    JAMA Psychiatry; 2019 Nov; 76(11):1150-1158. PubMed ID: 31411648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to chlorpyrifos and pyrethroid insecticides and symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in preschool children from the Odense Child Cohort.
    Fage-Larsen B; Andersen HR; Wesselhoeft R; Larsen PV; Dalsager L; Nielsen F; Rauh V; Bilenberg N
    Environ Res; 2024 Jan; 241():117679. PubMed ID: 37980991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Prenatal, Early Postnatal, or Current Exposure to Secondhand Smoke With Attention-Deficit/Hyperactivity Disorder Symptoms in Children.
    Lin LZ; Xu SL; Wu QZ; Zhou Y; Ma HM; Chen DH; Chen GB; Yu HY; Yang BY; Zeng XW; Hu LW; Dong GH
    JAMA Netw Open; 2021 May; 4(5):e2110931. PubMed ID: 34014325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children.
    Trønnes JN; Lupattelli A; Handal M; Skurtveit S; Ystrom E; Nordeng H
    JAMA Netw Open; 2021 Sep; 4(9):e2124324. PubMed ID: 34524436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index and childhood symptoms of depression, anxiety, and attention-deficit hyperactivity disorder: A within-family Mendelian randomization study.
    Hughes AM; Sanderson E; Morris T; Ayorech Z; Tesli M; Ask H; Reichborn-Kjennerud T; Andreassen OA; Magnus P; Helgeland Ø; Johansson S; Njølstad P; Davey Smith G; Havdahl A; Howe LD; Davies NM
    Elife; 2022 Dec; 11():. PubMed ID: 36537070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood attention-deficit/hyperactivity disorder symptoms are risk factors for obesity and physical inactivity in adolescence.
    Khalife N; Kantomaa M; Glover V; Tammelin T; Laitinen J; Ebeling H; Hurtig T; Jarvelin MR; Rodriguez A
    J Am Acad Child Adolesc Psychiatry; 2014 Apr; 53(4):425-36. PubMed ID: 24655652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children.
    Modesto T; Tiemeier H; Peeters RP; Jaddoe VW; Hofman A; Verhulst FC; Ghassabian A
    JAMA Pediatr; 2015 Sep; 169(9):838-45. PubMed ID: 26146876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Prenatal Exposure to Benzodiazepines and Z-Hypnotics With Risk of Attention-Deficit/Hyperactivity Disorder in Childhood.
    Sundbakk LM; Gran JM; Wood ME; Handal M; Skurtveit S; Nordeng H
    JAMA Netw Open; 2022 Dec; 5(12):e2246889. PubMed ID: 36520439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating late-onset ADHD: a population cohort investigation.
    Cooper M; Hammerton G; Collishaw S; Langley K; Thapar A; Dalsgaard S; Stergiakouli E; Tilling K; Davey Smith G; Maughan B; O'Donovan M; Thapar A; Riglin L
    J Child Psychol Psychiatry; 2018 Oct; 59(10):1105-1113. PubMed ID: 29683192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptible windows of prenatal and postnatal fine particulate matter exposures and attention-deficit hyperactivity disorder symptoms in early childhood.
    Chen WJ; Rector-Houze AM; Guxens M; Iñiguez C; Swartz MD; Symanski E; Ibarluzea J; Valentin A; Lertxundi A; González-Safont L; Sunyer J; Whitworth KW
    Sci Total Environ; 2024 Feb; 912():168806. PubMed ID: 38016567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between financial difficulty and childhood symptoms of attention deficit/hyperactivity disorder: a UK longitudinal cohort study.
    Russell AE; Ford T; Russell G
    Soc Psychiatry Psychiatr Epidemiol; 2018 Jan; 53(1):33-44. PubMed ID: 29124294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Genetic Risk Variants With Attention-Deficit/Hyperactivity Disorder Trajectories in the General Population.
    Riglin L; Collishaw S; Thapar AK; Dalsgaard S; Langley K; Smith GD; Stergiakouli E; Maughan B; O'Donovan MC; Thapar A
    JAMA Psychiatry; 2016 Dec; 73(12):1285-1292. PubMed ID: 27806167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of attention deficit hyperactivity disorder among preschool children Gharbia Governorate, Egypt.
    Younis EA; Shalaby SES; Abdo SAE
    BMC Psychiatry; 2023 Apr; 23(1):285. PubMed ID: 37098572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic background to attention deficit and hyperactivity disorder and attention deficit and hyperactivity disorder symptoms at the age of 5 years: the role of sleep duration.
    Morales-Muñoz I; Paavonen EJ; Kantojärvi K; Härkänen T; Saarenpää-Heikkilä O; Kylliäinen A; Himanen SL; Paunio T
    Sleep; 2023 Jul; 46(7):. PubMed ID: 36861221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-Deficit/Hyperactivity Disorder Symptoms Are Associated With Lower Adaptive Behavior Skills in Children With Autism.
    Yerys BE; Bertollo JR; Pandey J; Guy L; Schultz RT
    J Am Acad Child Adolesc Psychiatry; 2019 May; 58(5):525-533.e3. PubMed ID: 31029198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.